Please Wait
Applying Filters...
menu
    • menu
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Sodium thiosulfate (Na2S2O3)

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fennec to Present PEDMARK Research at 2026 ASCO Meeting
    Fennec to Present PEDMARK Research at 2026 ASCO Meeting

    21 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/21/3299825/0/en/fennec-pharmaceuticals-announces-new-research-supporting-integration-and-use-of-pedmark-at-the-2026-asco-annual-meeting.html

    GLOBENEWSWIRE
    21 May 2026
    Share Share
    Fennec Pharma Starts Cancer Study at Univ. of Arizona
    Fennec Pharma Starts Cancer Study at Univ. of Arizona

    07 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/07/3268978/0/en/Fennec-Pharmaceuticals-Announces-Investigator-Sponsored-Study-to-Be-Conducted-by-University-of-Arizona-Cancer-Center.html

    GLOBENEWSWIRE
    07 Apr 2026
    Share Share
    Swissmedic Approves PEDMARQSI to Prevent Kids' Hearing loss
    Swissmedic Approves PEDMARQSI to Prevent Kids' Hearing loss

    26 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/norgine-announces-swissmedic-approval-of-pedmarqsi-for-the-prevention-of-cisplatin-induced-hearing-loss-in-children-302725193.html

    PR NEWSWIRE
    26 Mar 2026
    Share Share
    Fennec Pharma Resolves PEDMARK Patent Litigation With Settlement
    Fennec Pharma Resolves PEDMARK Patent Litigation With Settlement

    16 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/16/3256242/0/en/Fennec-Pharmaceuticals-Announces-Settlement-Agreement-Resolving-PEDMARK-Patent-Litigation.html

    GLOBENEWSWIRE
    16 Mar 2026
    Share Share
    Fennec Pharma Partners With Tampa General Cancer Institute
    Fennec Pharma Partners With Tampa General Cancer Institute

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249229/0/en/Fennec-Pharmaceuticals-Announces-Clinical-Research-Collaboration-with-Tampa-General-Hospital-Cancer-Institute.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    Fennec Pharma Announces Trial for Metastatic TGCT at City of Hope
    Fennec Pharma Announces Trial for Metastatic TGCT at City of Hope

    09 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202214/0/en/Fennec-Pharmaceuticals-Announces-Investigator-Sponsored-Trial-to-Be-Conducted-by-City-of-Hope-in-Metastatic-Testicular-Germ-Cell-Tumors.html

    GLOBENEWSWIRE
    09 Dec 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.